BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29490409)

  • 1. Effects of Low- and High-Dose Chemotherapy Agents on Thrombogenic Properties of Extracellular Vesicles Derived from Breast Cancer Cell Lines.
    Aharon A; Sabbah AR; Issman L; Berkovich H; Copty R; Talmon Y; Brenner B
    Thromb Haemost; 2018 Mar; 118(3):480-489. PubMed ID: 29490409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
    Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
    Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.
    Campos A; Salomon C; Bustos R; Díaz J; Martínez S; Silva V; Reyes C; Díaz-Valdivia N; Varas-Godoy M; Lobos-González L; Quest AF
    Nanomedicine (Lond); 2018 Oct; 13(20):2597-2609. PubMed ID: 30338706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy administration to breast cancer patients affects extracellular vesicles thrombogenicity and function.
    Aharon A; Sabbah A; Ben-Shaul S; Berkovich H; Loven D; Brenner B; Bar-Sela G
    Oncotarget; 2017 Sep; 8(38):63265-63280. PubMed ID: 28968987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.
    Drucker A; Yoo BH; Khan IA; Choi D; Montermini L; Liu X; Jovanovic S; Younis T; Rosen KV
    Breast Cancer Res; 2020 Oct; 22(1):105. PubMed ID: 33023655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes.
    Graham R; Gazinska P; Zhang B; Khiabany A; Sinha S; Alaguthurai T; Flores-Borja F; Vicencio J; Beuron F; Roxanis I; Matkowski R; Liam-Or R; Tutt A; Ng T; Al-Jamal KT; Zhou Y; Irshad S
    Front Immunol; 2023; 14():1204224. PubMed ID: 37441083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cell type and culture condition on the procoagulant activity of human mesenchymal stromal cell-derived extracellular vesicles.
    Chance TC; Rathbone CR; Kamucheka RM; Peltier GC; Cap AP; Bynum JA
    J Trauma Acute Care Surg; 2019 Jul; 87(1S Suppl 1):S74-S82. PubMed ID: 31246910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obese adipose tissue extracellular vesicles raise breast cancer cell malignancy.
    Ramos-Andrade I; Moraes J; Brandão-Costa RM; Vargas da Silva S; de Souza A; da Silva C; Renovato-Martins M; Barja-Fidalgo C
    Endocr Relat Cancer; 2020 Oct; 27(10):571-582. PubMed ID: 32738129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput analysis of glycan sorting into extracellular vesicles.
    Pendiuk Goncalves J; Cruz Villarreal J; Walker SA; Tan XNS; Borges C; Wolfram J
    Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119641. PubMed ID: 37996057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
    Boddu VK; Zamzow P; Kramer MW; Merseburger AS; Gorantla SP; Klinger M; Cramer L; Sauer T; Gemoll T; von Bubnoff N; Gieseler F; Darabi M
    Cell Commun Signal; 2024 Feb; 22(1):129. PubMed ID: 38360687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The procoagulant effects of extracellular vesicles derived from hypoxic endothelial cells can be selectively inhibited by inorganic nitrite.
    Whelan C; Burnley-Hall N; Morris K; Rees DA; James PE
    Nitric Oxide; 2022 May; 122-123():6-18. PubMed ID: 35202833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
    Koizume S; Ito S; Yoshioka Y; Kanayama T; Nakamura Y; Yoshihara M; Yamada R; Ochiya T; Ruf W; Miyagi E; Hirahara F; Miyagi Y
    Thromb Haemost; 2016 Jan; 115(2):299-310. PubMed ID: 26446354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer.
    Li G; Sun Y; Huang Y; Lian J; Wu S; Luo D; Gong H
    BMC Cancer; 2023 May; 23(1):473. PubMed ID: 37221488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells.
    Ozawa PMM; Alkhilaiwi F; Cavalli IJ; Malheiros D; de Souza Fonseca Ribeiro EM; Cavalli LR
    Breast Cancer Res Treat; 2018 Dec; 172(3):713-723. PubMed ID: 30173296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
    Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
    Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of serum extracellular vesicles for novel small molecule inhibitor cell delivery.
    Hatzidaki E; Vlachou I; Elka A; Georgiou E; Papadimitriou M; Iliopoulos A; Papasotiriou I
    Anticancer Drugs; 2019 Mar; 30(3):271-280. PubMed ID: 30489291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation.
    Mørk M; Andreasen JJ; Rasmussen LH; Lip GYH; Pedersen S; Bæk R; Jørgensen MM; Kristensen SR
    Thromb Res; 2019 Jan; 173():141-150. PubMed ID: 30530119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Evaluation of Factors Affecting Extracellular Vesicle Uptake by Breast Cancer Cells.
    Stranford DM; Hung ME; Gargus ES; Shah RN; Leonard JN
    Tissue Eng Part A; 2017 Nov; 23(21-22):1274-1282. PubMed ID: 28586292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease dynamics in patients with acute myeloid leukemia: new biomarkers.
    Tzoran I; Rebibo-Sabbah A; Brenner B; Aharon A
    Exp Hematol; 2015 Nov; 43(11):936-43. PubMed ID: 26232698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCU-dependent negative sorting of miR-4488 to extracellular vesicles enhances angiogenesis and promotes breast cancer metastatic colonization.
    Zheng X; Lu S; He Z; Huang H; Yao Z; Miao Y; Cai C; Zou F
    Oncogene; 2020 Nov; 39(46):6975-6989. PubMed ID: 33067576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.